IRADIMED CORP - Common (IRMD)

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common
Shares outstanding
12,602,265
Total 13F shares
5,606,466
Share change
+111,868
Total reported value
$168,465,363
Price per share
$30.06
Number of holders
81
Value change
+$3,059,725
Number of buys
30
Number of sells
42

Institutional Holders of IRADIMED CORP - Common (IRMD) as of Q3 2022

As of 30 Sep 2022, IRADIMED CORP - Common (IRMD) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,606,466 shares. The largest 10 holders included Nine Ten Capital Management LLC, Soleus Capital Management, L.P., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, RK Capital Management, LLC, Russell Investments Group, Ltd., Bares Capital Management, Inc., Ranger Investment Management, L.P., and ACADIAN ASSET MANAGEMENT LLC. This page lists 81 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.